Professor Rinaldo Bellomo MBBS MD FRACP FCICM PGDipEcho
Professor Bellomo is a Professorial Fellow, Faculty of Medicine, University of Melbourne, Melbourne, Australia; Honorary Professor, Faculty of Medicine, Monash University, Melbourne Australia; Honorary Professorial Fellow, Faculty of Medicine, The University of Sydney, Sydney, Australia; Honorary Professorial Fellow, The George Institute, Sydney, Australia; Concurrent Professor, Faculty of Medicine, University of Nanjing, Nanjing, China; and Honorary Principal Research Fellow, Howard Florey Institute, University of Melbourne.
Professor Bellomo is the Director of Intensive Care Research at Austin Health. He is Co-Director of the Australian and New Zealand Intensive Care Research Centre (ANZIC-RC) - a National Health and Medical Research Council (NHMRC) Enabling Grant funded methods centre for investigator initiated clinical research that supports 15 staff, 12 PhD candidates, and research programs in traumatic brain injury, sepsis, transfusion, acute lung injury, nutrition and health economics. He is a NHMRC Practitioner Fellow and was Foundation Chair of the Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS-CTG). He is the recipient of awards including a NHMRC Achievement Award and an Austin Health Distinguished Scientist Award.
Professor Bellomo has published more than 800 papers, written more than 145 book chapters and edited 13 books in the field of intensive care medicine. As at December 2012 he had an h index of 68, total lifetime citations = 24,391; citations in 2011 = 3,700; and yearly citation rate over the past 5 years = 2,582. He is the Editor of the journal Critical Care and Resuscitation.
Professor Bellomo has been Chief Investigator in many successful grant applications. Over the past 10 years, he has been heavily involved in the design, execution, supervision and publication of several large randomised controlled trials published in the Lancet and the New England Journal of Medicine (NEJM) for >20,000 intensive care unit (ICU) patients randomised.